Using human papillomavirus (HPV) vaccine in controlled temperature chain (CTC): A solution looking for a problem? Or a solution to problems that are not systematically documented?
Spasenoska D. et al, (2025), Vaccine, 44, 126399 - 126399
Stakeholder Consultation Workshop on the Perceived Value of Thermostable Vaccines to Relieve Program Barriers: A Case Study from Côte d’Ivoire
Kahn A-L. et al, (2024), Vaccines, 12, 1414 - 1414
Exploring Important Attributes, the Potential Use Cases and Feasibility of Introduction of Measles and Rubella Microarray Patches (MR-MAPs): Insights from Nine Countries
Hasso-Agopsowicz M. et al, (2024), Vaccines, 12, 1084 - 1084
Design and implementation of a Primary Health Care (PHC) Toolbox for improving the impact of support from Global Development Partners
Spasenoska D. et al, (2024), BMC Global and Public Health, 2
National Immunization Program Decision Making Using the CAPACITI Decision-Support Tool: User Feedback from Indonesia and Ethiopia
Jansen M. et al, (2024), Vaccines, 12, 337 - 337
A Practical Guide to Full Value of Vaccine Assessments
Trotter C. et al, (2024), Vaccines, 12, 201 - 201
Controlled temperature chain for vaccination in low- and middle-income countries: a realist evidence synthesis
Seaman C. et al, (2022), Bulletin of the World Health Organization, 100, 491 - 502
Dynamics of life expectancy change during the transition to democracy in the ex-Yugoslav countries
Spasenoska D., (2022), Espace populations sociétés, 2022/2-3